Streetbeat News

Stock Prices

NLS

Nautilus, Inc. (NYSE:NLS) has entered into a securities purchase agreement with an institutional investor for a registered direct offering of 4,098,362 shares at $1.22 per share, totaling $5 million. The offering is expected to close on June 20, 2023. In a concurrent private placement, the company will issue warrants to purchase up to 4,098,362 shares of common stock.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:36 pm

BLBX

Blackboxstocks announced an $8.5 million investment stake in Evtec Group, issuing 2.4 million shares of Series B Convertible Preferred Stock. This move is an initial step towards a merger and helps Blackbox regain compliance with NASDAQ's stockholder equity requirement.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:35 pm

AFCG

AFC Gamma, Inc. (NASDAQ:AFCG) declares a $0.48 dividend for Q2 2023, announces a share repurchase program of up to $20 million, and provides portfolio updates. The company's management anticipates the dividend to be sustainable and is focused on deploying capital into deals with strong risk-adjusted returns.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:34 pm

POCI

Precision Optics Corporation (NASDAQ: POCI) has entered into definitive agreements for a private placement of 420,000 shares of common stock, resulting in gross proceeds of approximately $2.52 million. The closing is expected to occur on June 20, 2023.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:31 pm

MOD

PLAY

POWW

SG

TOL

The article lists the top 5 overbought consumer stocks in June, including AMMO, Inc. (POWW), Dave & Buster's Entertainment (PLAY), Sweetgreen (SG), Modine Manufacturing Company (MOD), and Toll Brothers (TOL). These stocks have RSI values above 70, indicating they may be overvalued and present an opportunity to go short.

Portfolio Pulse from Lisa Levin

June 15, 2023 | 12:31 pm

SPY

Core Retail Sales for May came in at 0.1%, in line with the 0.1% estimate.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:30 pm

MRSN

The FDA has issued a partial clinical hold on Mersana Therapeutics' (NASDAQ:MRSN) UP-NEXT and UPGRADE-A clinical trials of UpRi in platinum-sensitive ovarian cancer, following a submission of a recent aggregate safety report evaluating bleeding events. MRSN shares are down 64.8% at $3.36 during the premarket session.

Portfolio Pulse from Vandana Singh

June 15, 2023 | 12:30 pm

SPY

USA retail sales for May increased by 0.3% month-over-month, beating the estimated -0.1% and higher than the prior 0.4%.

Portfolio Pulse from Happy Mohamed

June 15, 2023 | 12:30 pm

DFLI

Dragonfly Energy's shares are trading higher following the announcement of a new US patent, which supports the company's continued momentum towards domestic non-flammable lithium battery production.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:29 pm

EDIT

Editas Medicine announced the pricing of an offering of common stock, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:28 pm